NCT01662869 2016-11-02A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal CancerHoffmann-La RochePhase 3 Completed564 enrolled
NCT01590719 2016-08-09A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal CancerHoffmann-La RochePhase 2 Completed123 enrolled